Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

Ju Cheol Son, Dong Woo Kang, Kwang Mo Yang, Kang Yell Choi, Tae Gen Son, Do Sik Min

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the present study, we evaluated the effects of PLD inhibition on cell survival, cell death and DNA damage after exposure to ionizing radiation (IR). Combined IR treatment and PLD inhibition led to an increase in the radiation-induced apoptosis of MDA-MB-231 metastatic breast cancer cells. The selective inhibition of PLD1 and PLD2 led to a significant decrease in the IR-induced colony formation of breast cancer cells. Moreover, PLD inhibition suppressed the radiation-induced activation of extracellular signal-regulated kinase and enhanced the radiation-stimulated phosphorylation of the mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Furthermore, PLD inhibition, in combination with radiation, was very effective at inducing DNA damage, when compared with radiation alone. Taken together, these results suggest that PLD may be a useful target molecule for the enhancement of the radiotherapy effect.

Original languageEnglish
Article numbere38
JournalExperimental and Molecular Medicine
Volume45
Issue number8
DOIs
Publication statusPublished - 2013 Aug 16

Fingerprint

Phospholipase D
Radiation Tolerance
Cells
Radiation
Breast Neoplasms
Ionizing radiation
Ionizing Radiation
DNA Damage
Phosphorylation
JNK Mitogen-Activated Protein Kinases
DNA
Extracellular Signal-Regulated MAP Kinases
Radiotherapy
p38 Mitogen-Activated Protein Kinases
Cell death
Drug Resistance
Pharmaceutical Preparations
Cell Survival
Cell Death
Chemical activation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Son, Ju Cheol ; Kang, Dong Woo ; Yang, Kwang Mo ; Choi, Kang Yell ; Son, Tae Gen ; Min, Do Sik. / Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells. In: Experimental and Molecular Medicine. 2013 ; Vol. 45, No. 8.
@article{c8c25cf7d466417696fa42ab1a1527b4,
title = "Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells",
abstract = "Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the present study, we evaluated the effects of PLD inhibition on cell survival, cell death and DNA damage after exposure to ionizing radiation (IR). Combined IR treatment and PLD inhibition led to an increase in the radiation-induced apoptosis of MDA-MB-231 metastatic breast cancer cells. The selective inhibition of PLD1 and PLD2 led to a significant decrease in the IR-induced colony formation of breast cancer cells. Moreover, PLD inhibition suppressed the radiation-induced activation of extracellular signal-regulated kinase and enhanced the radiation-stimulated phosphorylation of the mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Furthermore, PLD inhibition, in combination with radiation, was very effective at inducing DNA damage, when compared with radiation alone. Taken together, these results suggest that PLD may be a useful target molecule for the enhancement of the radiotherapy effect.",
author = "Son, {Ju Cheol} and Kang, {Dong Woo} and Yang, {Kwang Mo} and Choi, {Kang Yell} and Son, {Tae Gen} and Min, {Do Sik}",
year = "2013",
month = "8",
day = "16",
doi = "10.1038/emm.2013.75",
language = "English",
volume = "45",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "8",

}

Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells. / Son, Ju Cheol; Kang, Dong Woo; Yang, Kwang Mo; Choi, Kang Yell; Son, Tae Gen; Min, Do Sik.

In: Experimental and Molecular Medicine, Vol. 45, No. 8, e38, 16.08.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

AU - Son, Ju Cheol

AU - Kang, Dong Woo

AU - Yang, Kwang Mo

AU - Choi, Kang Yell

AU - Son, Tae Gen

AU - Min, Do Sik

PY - 2013/8/16

Y1 - 2013/8/16

N2 - Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the present study, we evaluated the effects of PLD inhibition on cell survival, cell death and DNA damage after exposure to ionizing radiation (IR). Combined IR treatment and PLD inhibition led to an increase in the radiation-induced apoptosis of MDA-MB-231 metastatic breast cancer cells. The selective inhibition of PLD1 and PLD2 led to a significant decrease in the IR-induced colony formation of breast cancer cells. Moreover, PLD inhibition suppressed the radiation-induced activation of extracellular signal-regulated kinase and enhanced the radiation-stimulated phosphorylation of the mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Furthermore, PLD inhibition, in combination with radiation, was very effective at inducing DNA damage, when compared with radiation alone. Taken together, these results suggest that PLD may be a useful target molecule for the enhancement of the radiotherapy effect.

AB - Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the present study, we evaluated the effects of PLD inhibition on cell survival, cell death and DNA damage after exposure to ionizing radiation (IR). Combined IR treatment and PLD inhibition led to an increase in the radiation-induced apoptosis of MDA-MB-231 metastatic breast cancer cells. The selective inhibition of PLD1 and PLD2 led to a significant decrease in the IR-induced colony formation of breast cancer cells. Moreover, PLD inhibition suppressed the radiation-induced activation of extracellular signal-regulated kinase and enhanced the radiation-stimulated phosphorylation of the mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Furthermore, PLD inhibition, in combination with radiation, was very effective at inducing DNA damage, when compared with radiation alone. Taken together, these results suggest that PLD may be a useful target molecule for the enhancement of the radiotherapy effect.

UR - http://www.scopus.com/inward/record.url?scp=84882988351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882988351&partnerID=8YFLogxK

U2 - 10.1038/emm.2013.75

DO - 10.1038/emm.2013.75

M3 - Article

C2 - 23989060

AN - SCOPUS:84882988351

VL - 45

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 8

M1 - e38

ER -